These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23142334)

  • 21. Emerging concepts in osteoporosis and bone strength.
    Rubin CD
    Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Swiss guidance for the diagnosis and management of osteoporosis].
    Kraenzlin ME
    Rev Med Suisse; 2013 Jun; 9(390):1272, 1274-8. PubMed ID: 23821846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis.
    Izuora KE; Alazraki N; Byrd-Sellers J; Tangpricha V; Nanes MS
    Am J Med Sci; 2011 Jul; 342(1):5-8. PubMed ID: 21412137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
    Felsenberg D; Boonen S
    Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on dual-energy x-ray absorptiometry.
    Blake GM; Fogelman I
    Semin Nucl Med; 2010 Jan; 40(1):62-73. PubMed ID: 19958851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology insight: noninvasive assessment of bone strength in osteoporosis.
    Bouxsein ML
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):310-8. PubMed ID: 18431371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of bone densitometry in the framework of prevention and therapy of osteoporosis. Example of a systematic evaluation (health technology assessment)].
    Lühmann D; Kohlmann T; Raspe H
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):475-81. PubMed ID: 10996937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining bone health and fracture risk in West Virginia: the World Health Organization FRAX assessment tool.
    Shuler FD; Conjeski J
    W V Med J; 2011; 107(5):12-7. PubMed ID: 22034804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone densitometry as a screening tool for osteoporosis in postmenopausal women.
    Radiol Manage; 1998; 20(2):43-54. PubMed ID: 10179192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important determinants of bone strength: beyond bone mineral density.
    Friedman AW
    J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology of bone and joint disease - the present and future - . The present situation and problems associated with medical screening systems for osteoporosis].
    Nakatoh S
    Clin Calcium; 2014 May; 24(5):719-26. PubMed ID: 24769683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fracture risk perception study: patient self-perceptions of bone health often disagree with calculated fracture risk.
    Grover ML; Edwards FD; Chang YH; Cook CB; Behrens MC; Dueck AC
    Womens Health Issues; 2014; 24(1):e69-75. PubMed ID: 24439949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis.
    Nanes MS; Kallen CB
    Semin Nucl Med; 2014; 44(6):439-50. PubMed ID: 25362234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting bone strength other than osteoporosis.
    Ratti C; Vulcano E; Canton G; Marano M; Murena L; Cherubino P
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S9-11. PubMed ID: 24046057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis in premenopause. When are screening and treatment prudent?
    Derk CT
    Postgrad Med; 2006; 119(1):8-15. PubMed ID: 16913642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
    McCloskey EV; Vasikaran S; Cooper C;
    J Clin Densitom; 2011; 14(3):220-2. PubMed ID: 21810528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone densitometry in children and adolescents.
    Estrada A; Ramnitz MS; Gafni RI
    Curr Opin Obstet Gynecol; 2014 Oct; 26(5):339-46. PubMed ID: 25144595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone density measurement for the prediction of risk of fracture in osteoporosis].
    Meng X
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):579-80. PubMed ID: 8697919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.